XML 31 R14.htm IDEA: XBRL DOCUMENT v3.6.0.2
Stockholders' Equity
12 Months Ended
Dec. 31, 2016
Equity [Abstract]  
Stockholders' Equity
8. STOCKHOLDERS’ EQUITY

Earnings Per Share

The following table sets forth the computation of basic and diluted earnings per share (in thousands, except share and per share data):

 

     Year Ended December 31,  
     2016      2015      2014  

Numerator:

        

Net income

   $ 67,847       $ 48,098       $ 41,521   
  

 

 

    

 

 

    

 

 

 

Denominator:

        

Basic weighted average shares outstanding

     29,394,559         31,350,542         32,319,649   

Effect of dilutive securities:

        

SARS and options

     125,119         197,299         262,730   

Restricted stock

     92,991         134,668         168,695   
  

 

 

    

 

 

    

 

 

 

Diluted weighted average shares outstanding

     29,612,669         31,682,509         32,751,074   
  

 

 

    

 

 

    

 

 

 

Basic earnings per share

   $ 2.31       $ 1.53       $ 1.28   
  

 

 

    

 

 

    

 

 

 

Diluted earnings per share

   $ 2.29       $ 1.52       $ 1.27   
  

 

 

    

 

 

    

 

 

 

Diluted earnings per share is computed using the weighted average number of shares determined for the basic earnings per share computation plus the dilutive effect of common stock equivalents using the treasury stock method. The computation of diluted earnings per share excludes the following potentially dilutive securities because the effect would be anti-dilutive:

 

     Year Ended December 31,  
     2016      2015      2014  

Restricted stock and stock options

     12         501         2,633   

Stock appreciation rights

     4,631         5,828         1,969   

Stock Repurchase Programs

On February 19, 2014, the Board of Directors authorized a common stock repurchase program of up to $50 million shares of the Company’s outstanding common stock (February 2014 Stock Repurchase Program). This authorization had no expiration date. During 2014, the Company repurchased 1,657,919 shares for $50.0 million, which completed the authorization under the February 2014 Stock Repurchase Program.

On October 23, 2014, the Board of Directors authorized a common stock repurchase program of up to 2.0 million shares of the Company’s outstanding common stock (October 2014 Stock Repurchase Program). This authorization had no expiration date. During 2015, the Company repurchased 1,134,300 shares for $45.2 million under the October 2014 Stock Repurchase Program. On October 22, 2015, the Board of Directors terminated the October 2014 Stock Repurchase Program and adopted a new stock repurchase program of up to 3.15 million shares of the Company’s outstanding common stock (October 2015 Stock Repurchase Program). This authorization terminated on December 31, 2016. During 2016, the Company repurchased 1,578,952 shares for $53.3 million under the October 2015 Stock Repurchase Program.

 

On February 16, 2017, the Board of Directors authorized a common stock repurchase program of up to 2.961 million shares of the Company’s outstanding common stock (February 2017 Stock Repurchase Program). As of the date of this report, the Company has made no repurchases under the February 2017 Stock Repurchase Program.